Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
暂无分享,去创建一个
P. Nyirjesy | M. Spitzer | R. Sobel | J. Sobel | O. Goje | S. Goldstein | N. Azie | D. Angulo | B. Faught | Shelagh B. Larson | Thomas King | Ryan H. Sobel